来自Arbutus的结论:
•Two chemically distinct cyclophilin inhibitors showed potent anti-PPIAse, and anti-HCV replicon activity
•Neither inhibitor showed consistent anti HBV effects in vitro
•When observed, in vitro antiviral activity correlated with cytostatic effects
•In two HBV animal models cyclophilin inhibitors did not result in any detectable effect, on either viral antigens or nucleic acids
•siRNA knockdown of cyclophilins in vitro and in vivo did not result in antiviral effects
•Our data confirm that different viruses indeed have different requirements for cyclophilin functions, and that HBV is relatively insensitive to cyclophilin inhibition
来自Ciclofilin的结果:
• CPI-431-32 completely blocks HBsAg production/secretion from infected and transfected cells
• CPI-431-32 additionally suppresses HBV cellular entry and replication
• CPI-431-32 reduces liver HBV DNA in HBV1.3 transgenic mice